# LUNG TUMOURS: CARCINOMA OF THE BRONCHUS

Accounts for ~19% of all cancers + 27% of cancer deaths: 40,000 cases/yr in the UK.

Incidence increasing in women.

Only 5% 'cured'.

### RISK FACTORS

**Cigarette smoking** is a major risk factor.

Others:

- asbestos
- chromium
- arsenic
- iron oxides
- radiation (radon gas)

### HISTOLOGY

Clinically the most important division is between **small cell** (SCLC) and **non-small cell** (NSCLC).

Types of carcinoma of the bronchus:

- squamous: 35%

- adenocarcinoma: 27%

- **small (oat) cell: 20%**

- large cell: 10%

- alveolar cell carcinoma: rare, <1%


### SYMPTOMS + SIGNS

Symptoms:

- cough: 80%

- haemoptysis: 70%

- dyspnoea: 60%

- chest pain: 40%

- recurrent or slowly resolving pneumonia

- lethargy

- anorexia

- weight loss

Signs:

- cachexia 

- anaemia

- clubbing

- HPOA: hypertrophic pulmonary osteoarthropathy, causing wrist pain

- supraclavicular or axillary nodes

Chest signs: none, or - 

- consolidation

- collapse

- pleural effusion

Signs of metastases:

- bone tenderness

- hepatomegaly

- confusion

- fits

- focal CNS signs

- cerebellar syndrome

- proximal myopathy

- peripheral neuropathy

### COMPLICATIONS

Local:

- recurrent laryngeal nerve palsy

- phrenic nerve palsy

- SVC obstruction

- Horner's syndrome (Pancoast's tumour)

- rib erosion

- pericarditis

- atrial fibrillation

Metastatic:

- brain

- bone: bone pain, anaemia, hypercalcaemia

- liver

- adrenals: Addison's

Endocrine: ectopic hormone secretion, e.g. - 

- SIADH: hyponatraemia + high ADH (SCLC)
- ACTH: Cushing's (SCLC)
- PTH: hypercalcaemia (squamous cell tumours)

Non-metastatic neurological:

- confusion

- fits

- cerebellar syndrome

- proximal myopathy

- neuropathy

- polymyositis

- Lambert-Eaton syndrome

Others:

- clubbing

- HPOA

- dermatomyositis

- acanthosis nigricans

- thrombophlebitis migrans

### INVESTIGATIONS

**Cytology**: sputum + pleural fluid, minimum 20mL.

**CXR**:

- peripheral nodule
- hilar enlargement
- consolidation
- lung collapse
- pleural effusion
- bony secondaries

May be able to do percutaneous **fine needle aspiration** or **biopsy** on peripheral lesions + superficial lymph nodes.

**CT**: to stage tumour + guide bronchoscopy.

**Bronchoscopy**: to give histology + assess operability, ± **endobronchial US** for assessment + biopsy.

F-deoxyglucose **PET** or PET/CT: helps to stage.

**Radionuclide bone scan**: if suspect metastases.

**Lung function tests**: help assess suitability for lobectomy.

### MGMT

#### NON-SMALL CELL TUMOURS

For peripheral tumours + no metastatic spread (stage I/II): **excision**.

Poor respiratory reserve: **curative radiotherapy**.

More advanced disease:**chemotherapy ± radiotherapy**.

Chemo regimens may be platinum-based, e.g. with monoclonal Abs targetting epidermal growth factor: **cetuximab**.

#### SMALL CELL TUMOURS

Nearly always disseminated at presentation.

May respond to **chemotherapy** but invariably relapse.

- **cyclophosphamide** + **doxorubicin** + **vincristine** + **etoposide**

- OR **cisplatin ± radiotherapy** if limited disease

#### PALLIATION

**Radiotherapy**, used for:

- bronchial obstruction
- SVC obstruction
- haemoptysis
- bone pain
- cerebral metastases

For SVC obstruction: **SVC stent + radiotherapy + dexamethosone**.

**Endobronchial therapy**:

- tracheal stenting
- cryotherapy
- laser
- brachytherapy: radioactive source placed close to tumour

For symptomatic pleural effusions: **pleural drainage/pleurodesis**.

Drugs:

- analgesia
- steroids
- antiemetics
- cough linctus (codeine)
- bronchodilators
- antidepressants


### PROGNOSIS

Non-small cell: 50% 2y survival without spread; 10% with spread.

Small cell: median survival is 3/12 if untreated; 1-1.5y if treated.

### PREVENTION

Stop smoking.

Prevent occupational exposure to carcinogens.

# OTHER LUNG TUMOURS

Bronchial adenoma:

- rare
- slow-growing
- 90% carcinoid
- 10% cylindromas
- Rx: surgery

Hamartoma:

- rare
- benign
- CT shows lobulated mass ± flecks of calcification
- ?excise to exclude malignancy

Mesothelioma.